Pharmaceutical

Image

Global Fascioliasis Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Fascioliasis Market, By Treatment (Triclabendazole, Nitazoxanide, Others), End-Users (HospitalsHomecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Fascioliasis Market

Fascioliasis Market Analysis and Size

The global fascioliasis market is expected to witness significant growth during the forecast period. According to the WHO, fascioliasis has been witnessed in more than 75 nations worldwide with the widespread infected global population of 2.4 million. The most affected areas include South America, East-Asia, and South-east Asia. Compromised hygiene and sanitation are the major reasons for the infections. The symptoms of this disease are primarily visible at 9-11 weeks of the onset of infections. The diagnosis includes eosinophil count, computer tomography scans and ultrasound. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global fascioliasis market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Fascioliasis Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Treatment (Triclabendazole, Nitazoxanide, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Emcure Pharmaceuticals Limited. (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited(India), Aurobindo Pharma (India), Abbvie Inc (U.S.), Melinta Therapeutics, llc (U.S.), Janssen Global Services, LLC (U.S.), Norbrook (U.K.), Procyon Life Sciences (India)

Market Opportunities

  • Increased Clinical Trials and Development
  • Increasing Demand for Retail Pharmacies

Market Definition

Fascioliasis, also known as liver fluke infestation, is a sub-group of neglected tropical disease defined as parasitic flatworms infections caused by fasciola hepatica. The typical signs and symptoms of fascioliasis are nausea, irregular episodes of fever, abdominal pain, diarrhea and eosinophilia. Individuals infected with this infection mostly don’t show any symptoms, and sometimes symptoms arise associated with the biliary system. In rare cases, long-term complications can also develop

Global Fascioliasis Market Dynamics

Drivers

  • Government Initiatives  

The government has numerous supportive schemes along with WHO to increase awareness of treatments, subsidized medicines and reimbursement policies. Government has active funding aids and programs to boost the merging drug manufacturers for fascioliasis treatment. This boosts the market growth.

  • High Prevalence of Liver Fluke Infection

According to the Centers for Disease Control and Prevention (CDC), fascioliasis occurs in many areas of the world. Furthermore, fascioliasis is more prevalent in animals than in people. The number of infected people is thought to exceed two million worldwide. In addition, according to the study published in The American Journal of Tropical Medicine and Hygiene, the occurrence of 2.6 million infected and 91 million at risk of developing an infection, worldwide. This boosts the market growth.

Opportunities

  • Increased Clinical Trials and Development

The increasing clinical trials and drug developmental processes are creating much opportunities for the market growth. For instance, Triclabendazole is a benzimidazole compound used regularly in veterinary practice to treat fascioliasis. In 1997, after several clinical trials using triclabendazole to treat fascioliasis, the WHO recommended the drug be placed on the essential drugs list.Thus, these factors are essential for the market growth.

  • Increasing Demand for Retail Pharmacies

The rise in the number of drugs for fascioliasis being delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for the market growth. Additionally, patients choose retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Adverse Effects of Fascioliasis Treatment drugs

Severe adverse effects associated with the fascioliasis treatment drugs are expected to hamper the market growth. Effects related to Nitazoxanide such as nausea, discoloured urine, headache, stomach ache, then effects of Triclabendazole such as heavy sweating, dizziness, nausea, hives, itching hamper the growth of the market.

  • High Cost

The huge expenditure associated with these agents surely hamper the market growth. Although drug manufactures are thinking to reduce the cost of medicines such as Triclabendazole. Furthermore, development of more effective and safer medications such as Nitazoxanide, niclofolan emetine, chloroquine and heptachlor-para-xylol are under the process after the recommendation by WHO.

This global fascioliasis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global fascioliasis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Fascioliasis Market

COVID-19 pandemic has shaken the market in a big way. Several countries, such as China, the major global supplier of active pharmaceutical ingredients and chemicals, were initially infected by the virus. This has undesirably impacted the fascioliasis treatment market. Although, the global fascioliasis treatment market is anticipated to pace with the high growth trend with the restoration of normal situation. People from across the globe are increasing focus on strengthening their immunity because of the pandemic. As proteins are considered one of the significant ingredients leading to good health of an individual, the demand for high-quality milk and protein products has been increased. Thus, the awareness about various infections is also on the roll. All these factors contribute to the market size growth in the post pandemic era.

Global Fascioliasis Market Scope

The global fascioliasis market is segmented on the basis of treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Triclabendazole
  • Nitazoxanide
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Fascioliasis Market Regional Analysis/Insights

The global fascioliasis market is analysed and market size insights and trends are provided by treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global fascioliasis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global fascioliasis market throughout the forecasted period due to the high adoption of fascioliasis drugs, dependency on livestock as occupation and increased patient awareness level as well as high prevalence of leishmaniasis.

North America dominates the market due to the presence of refined healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Fascioliasis Market Share Analysis

The global fascioliasis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global fascioliasis market.

Key players operating in the global fascioliasis market include:

  • Emcure Pharmaceuticals Limited. (India)
  • Cipla Inc. (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • Johnson & Johnson Private Limited (U.S.),
  • Mylan N.V. (U.S.)
  • Sun Pharmaceutical Industries Limited(India)
  • Aurobindo Pharma (India)
  • Abbvie Inc (U.S.)
  • Melinta Therapeutics, llc (U.S.)
  • Janssen Global Services, LLC (U.S.)
  • Norbrook (U.K.)
  • Procyon Life Sciences (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Factors such as high prevalence of liver fluke infection and government initiatives are acting as the major drivers for the global fascioliasis market.
The key opportunities in the Fascioliasis Market in terms of increased Clinical Trials and Development, increasing Demand for Retail Pharmacies.
The major players in the Fascioliasis Market are Emcure Pharmaceuticals Limited. (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited(India), Aurobindo Pharma (India), Abbvie Inc (U.S.), Melinta Therapeutics, llc (U.S.), Janssen Global Services, LLC (U.S.), Norbrook (U.K.), Procyon Life Sciences (India).
The country covered in the Fascioliasis Market are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials